Business Description
Mycenax Biotech Inc
ISIN : TW0004726005
Total Employee Number:
378Description
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards. The company's main operating region is located in Taiwan.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.67 | |||||
Debt-to-EBITDA | -7.88 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.36 | |||||
Beneish M-Score | -2.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.9 | |||||
3-Year EBITDA Growth Rate | 12.3 | |||||
3-Year EPS without NRI Growth Rate | 5.2 | |||||
3-Year FCF Growth Rate | 49.6 | |||||
3-Year Book Growth Rate | -20.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.84 | |||||
9-Day RSI | 39.87 | |||||
14-Day RSI | 41.2 | |||||
3-1 Month Momentum % | -16.44 | |||||
6-1 Month Momentum % | -30.83 | |||||
12-1 Month Momentum % | -37.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.7 | |||||
Quick Ratio | 0.58 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 36.42 | |||||
Days Sales Outstanding | 52.75 | |||||
Days Payable | 19.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -3.47 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -24.51 | |||||
Operating Margin % | -54.77 | |||||
Net Margin % | -60.61 | |||||
EBITDA Margin % | -18.39 | |||||
FCF Margin % | -17.06 | |||||
OCF Margin % | -3.68 | |||||
ROE % | -25.12 | |||||
ROA % | -13.58 | |||||
ROIC % | -12.28 | |||||
3-Year ROIIC % | 1.14 | |||||
ROC (Joel Greenblatt) % | -18.74 | |||||
ROCE % | -17.45 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 6.86 | |||||
PB Ratio | 3.16 | |||||
Price-to-Tangible-Book | 3.26 | |||||
EV-to-EBIT | -14.08 | |||||
EV-to-EBITDA | -43.48 | |||||
EV-to-Revenue | 8 | |||||
EV-to-FCF | -48.74 | |||||
Price-to-GF-Value | 0.51 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Earnings Yield (Greenblatt) % | -7.1 | |||||
FCF Yield % | -2.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mycenax Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 740.238 | ||
| EPS (TTM) (NT$) | -2.17 | ||
| Beta | -0.4744 | ||
| 3-Year Sharpe Ratio | -0.52 | ||
| 3-Year Sortino Ratio | -0.75 | ||
| Volatility % | 16.77 | ||
| 14-Day RSI | 41.2 | ||
| 14-Day ATR (NT$) | 0.836748 | ||
| 20-Day SMA (NT$) | 25.3 | ||
| 12-1 Month Momentum % | -37.04 | ||
| 52-Week Range (NT$) | 23.95 - 40 | ||
| Shares Outstanding (Mil) | 207.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mycenax Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mycenax Biotech Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mycenax Biotech Inc Frequently Asked Questions
What is Mycenax Biotech Inc(ROCO:4726)'s stock price today?
The current price of ROCO:4726 is NT$24.50. The 52 week high of ROCO:4726 is NT$40.00 and 52 week low is NT$23.95.
When is next earnings date of Mycenax Biotech Inc(ROCO:4726)?
The next earnings date of Mycenax Biotech Inc(ROCO:4726) is .
Does Mycenax Biotech Inc(ROCO:4726) pay dividends? If so, how much?
Mycenax Biotech Inc(ROCO:4726) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mycenax Biotech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers